Ejal 40

£33.60 £28.00

Ejal 40® is a non-crosslinked hyaluronic acid with a medium molecular weight, developed to regenerate and rebuild the fundamental structure of the extracellular matrix. Instead of traditional multipoint mesotherapy, we recommend biorevitalisation using the innovative 4-point BRP (BioRevitalisation Point) technique.

Formulated with pure-class hyaluronic acid, Ejal 40® delivers enhanced efficacy and long-lasting results thanks to its optimal molecular weight (1200–1800 kDa). It has a smooth, gel-like consistency and is manufactured by Medixa, a reputable Italian company. The product holds a CE certificate for medical devices, ensuring high standards of safety and quality.

Details

The Ejal 40® treatment involves injecting small amounts (0.2–0.25ml) of the product into four BRP points on each side of the face. In some cases, a fifth injection point is added centrally on the cheeks. This technique minimises tissue expansion, making the procedure virtually painless while still delivering visible tightening, smoothing, and lifting effects.

Recommended Protocols:

Ages 50+: 3 sessions at one-month intervals, followed by 1 session every 3 months.
Ages 40+: 2–3 sessions at one-month intervals, followed by maintenance treatments every 3–4 months.

Results typically last 12 to 18 months.

Indications

Sagging or lax skin
Dehydrated and dry skin
Loss of facial contour
Fine lines and wrinkles
Skin affected by stretch marks or pigmentation
Supportive therapy before or after dermal filler treatments

Composition

Hyaluronic Acid (non-crosslinked): 40mg / 2ml
Lidocaine: None

Packaging

1 pre-filled syringe (2ml)
2 sterile needles (30G ½”, 0.3 x 13mm)

Contraindications

Known allergy to hyaluronic acid
Active skin inflammation or infection
Tendency to form hypertrophic scars
Pregnancy or breastfeeding
Ongoing antibiotic therapy

Treatment Method

Ejal 40® should be administered by a qualified professional trained in the BRP technique. The skin should be properly disinfected prior to treatment, and patients must be informed about potential side effects.

After injection, the area should be gently massaged to ensure even distribution. Minor swelling, redness, or bruising may occur and typically resolves within a few hours to several days.